Freemont Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-101,600
Closed -$11.1M 133
2026
Q1
$11.1M Sell
101,600
-10,300
-9% -$1.47M 1.69% 16
2025
Q4
$18.6M Buy
111,900
+97,800
+694% +$16.4M 3.25% 6
2025
Q3
$2.76M Sell
14,100
-105,400
-88% -$17.3M 1.38% 21
2025
Q2
$10.8M Buy
119,500
+28,000
+31% +$2.21M 1.62% 19
2025
Q1
$5.46M Buy
+91,500
New +$8.46M 1.8% 15

Other funds holding ALAB

Freemont Management's ALAB Position: Q2 2026 in Review

Freemont Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 101,600 shares — an estimated $11.1M sold.

Freemont Management first reported a position in ALAB in Q1 2025 and held it in 5 quarters. The position peaked at $18.6M in Q4 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Freemont Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Freemont Management sold 101,600 Astera Labs shares in Q2 2026, an estimated $11.1M.
  • Freemont Management first reported a position in Astera Labs in Q1 2025 and held it in 5 quarters.
  • Freemont Management's Astera Labs position peaked at $18.6M in Q4 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Freemont Management's 13F filing for Q2 2026, filed 11 Aug 2026.